PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $67,362 | -45.2% | 14,122 | +0.0% | 0.00% | – |
| Q4 2022 | $122,818 | -38.3% | 14,117 | -15.8% | 0.00% | – |
| Q3 2022 | $199,000 | +32.7% | 16,766 | +59.1% | 0.00% | – |
| Q2 2022 | $150,000 | -27.5% | 10,540 | +17.9% | 0.00% | – |
| Q4 2021 | $207,000 | -20.4% | 8,942 | +2.4% | 0.00% | – |
| Q3 2021 | $260,000 | -15.3% | 8,736 | -3.0% | 0.00% | – |
| Q2 2021 | $307,000 | +23.8% | 9,004 | +123.6% | 0.00% | – |
| Q4 2020 | $248,000 | – | 4,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |